Company / Operating Income per Share
PharmaCyte Biotech, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.06
FY2025
5-year range
-$3.50 / -$0.21
FY2021-FY2025
Trend
-175.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-3.50 in FY2021 to $-0.00 in FY2020.
Based on SEC 10-K filings.
-1.06 in FY2025.
Declined from $-0.21 to $-1.06 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 175.8% year-over-year.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.06 | -175.8% |
| FY2024 | -$0.38 | -81.4% |
| FY2023 | -$0.21 | +90.7% |
| FY2022 | -$2.28 | +34.9% |
| FY2021 | -$3.50 | -101205.7% |
| FY2020 | -$0.00 | +49.8% |
| FY2019 | -$0.01 | -40.4% |
| FY2018 | -$0.00 | +36.9% |
| FY2017 | -$0.01 | +70.0% |
| FY2016 | -$0.03 | -962.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026